Latest Funds From Operations News

Page 27 of 37
Regis Healthcare reveals strong first-half FY25 financial results with rising occupancy and earnings, while gearing up for significant regulatory reforms under the new Aged Care Act effective July 2025.
Ada Torres
Ada Torres
7 May 2025
Scentre Group reports rising customer visits and record business partner sales, while advancing major Westfield redevelopments and reaffirming 2025 earnings guidance.
Eva Park
Eva Park
7 May 2025
Vicinity Centres reports a robust third quarter for FY25, driven by strong retailer demand and shopper confidence, highlighted by the successful launch of The Market Pavilion at Chadstone.
Eva Park
Eva Park
6 May 2025
Vicinity Centres reports a robust third quarter for FY25, buoyed by record visitation at Chadstone’s new Market Pavilion and strong retail sales growth. The company now expects full-year earnings at the top end of guidance, underpinned by resilient portfolio metrics and strategic asset management.
Eva Park
Eva Park
6 May 2025
CL8 Holdings has completed a strategic merger of its Carly car subscription business with Carbar Holdings, combining two of Australia’s leading platforms. The company retains a stake in the merged entity and plans to pursue fresh growth opportunities while streamlining operations.
Victor Sage
Victor Sage
2 May 2025
GPT Group unveiled a strategic pivot towards co-investment alongside capital partners, reporting resilient 2024 earnings and expanding its retail management platform through key partnerships and asset acquisitions.
Eva Park
Eva Park
1 May 2025
Baby Bunting Group unveils its ambitious ‘Store of the Future’ strategy, targeting a return to double-digit EBITDA margins through store refurbishments, new small format pilots, and enhanced omni-channel capabilities. The company sets FY25 NPAT guidance between $10 million and $12.5 million, underpinned by a 40% gross margin target.
Logan Eniac
Logan Eniac
1 May 2025
Baby Bunting reports a 2.9% year-to-date comparable store sales growth and opens an innovative new store format in Melbourne, raising its FY25 NPAT guidance amid strong early results.
Logan Eniac
Logan Eniac
1 May 2025
Recce Pharmaceuticals reports strong Phase II clinical trial results for its topical anti-infective R327G, achieving a 93% efficacy rate in treating ABSSSI, alongside a significant capital raise to fund upcoming Phase III trials.
Ada Torres
Ada Torres
30 Apr 2025
NT Minerals Limited reported a cautious cash flow profile for the March 2025 quarter, with operating outflows offset by strategic financing, securing liquidity for the foreseeable future.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Nanoveu Limited has completed its strategic acquisition of EMASS, advancing its foothold in ultra-low-power AI-driven edge computing. The company also strengthened its leadership team and secured additional capital to fuel growth.
Sophie Babbage
Sophie Babbage
30 Apr 2025
Anax Metals reports strong progress at its Whim Creek Copper-Zinc Project, confirming high copper and zinc recoveries via scaled-up bioleaching tests and advancing negotiations with multiple strategic partners. A new tenement application near a major gold deposit further expands its Pilbara footprint.
Maxwell Dee
Maxwell Dee
30 Apr 2025